☆ 4.6 Article

Pretreatment integrase strand transfer inhibitor resistance in Tianjin, China

CHINESE MEDICAL JOURNAL (2023)

Related references

Note: Only part of the references are listed.

Editorial Material Medicine, General & Internal

Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults 2022 Recommendations of the International Antiviral Society-USA Panel

Rajesh T. Gandhi et al.

Summary: Based on new data, recommendations are provided to clinicians on the use of antiretroviral drugs for the treatment and prevention of HIV, as well as on laboratory monitoring, care of aging individuals with HIV, substance use disorder, and new challenges such as COVID-19 and monkeypox virus infection. The initiation of antiretroviral therapy as soon as possible after HIV diagnosis is recommended, along with addressing barriers to care and ensuring access to medication and adherence support. Advances in treatment and prevention of HIV have improved outcomes, but challenges and opportunities still exist.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2023)

Add to Collection

Article Infectious Diseases

Primary resistance to integrase inhibitors in Shenzhen

Yue Zhu et al.

Summary: This study aims to describe the prevalence of resistance to integrase and drug resistance mutations (DRMs) among ART-naive patients in Shenzhen, China. It found that the prevalence of INSTI resistance in Shenzhen in 2020 was relatively high. Continued surveillance for INSTI resistance is recommended and treatment regimens should be chosen based on the pattern of INSTI resistance, with dolutegravir or bictegravir as the first recommended options.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2023)

Add to Collection

Article Immunology

Life expectancy after 2015 of adults with HIV on long-term antiretroviral therapy in Europe and North America: a collaborative analysis of cohort studies

Adam Trickey et al.

Summary: Life expectancy has increased for people with HIV on antiretroviral therapy (ART). Latest prognosis data show that the survival rate of adults with HIV who have been on ART for at least 1 year in Europe and North America is similar to that of the general population, regardless of the starting time of ART. However, individuals with low CD4 counts at the start of treatment have lower life expectancy, highlighting the importance of early diagnosis and sustained treatment of HIV.

LANCET HIV (2023)

Add to Collection

Article Infectious Diseases

Pre-treatment and acquired antiretroviral drug resistance among people living with HIV in Tianjin, China

Liying Gao et al.

Summary: This study investigated the prevalence and patterns of pre-treatment and acquired HIV drug resistance mutations among people living with HIV on antiretroviral therapy in Tianjin, China. The results showed that drug resistance mutations were highly prevalent among the participants, highlighting the need for routine resistance testing and viral load surveillance for successful long-term treatment.

HIV MEDICINE (2022)

Add to Collection

Article Microbiology

Drug Resistance to Integrase Strand-Transfer Inhibitors among HIV-1-Infected Adults in Guangdong, China

Yun Lan et al.

Summary: The study revealed a comparatively low prevalence of INSTI-related drug resistance among HIV-1-infected patients in Guangdong province, China, with some ART-experienced individuals showing mutations conferring resistance to INSTIs. Therefore, surveillance should be reinforced before transitioning to INSTI-containing regimens.

PATHOGENS (2022)

Add to Collection

Review Infectious Diseases

HIV-1 integrase strand transfer inhibitors: a review of current drugs, recent advances and drug resistance

Nokuzola Mbhele et al.

Summary: Antiretroviral therapy is crucial in controlling the HIV epidemic, with integrase strand transfer inhibitors (INSTIs) becoming more common. INSTIs have a higher genetic barrier to resistance, with DTG showing even higher resistance barriers and CAB being used as the first long-acting agent in HIV-1 treatment.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2021)

Add to Collection

Article Infectious Diseases

Optimizing Treatment for Adults with HIV/AIDS in China: Successes over Two Decades and Remaining Challenges

Wei Cao et al.

CURRENT HIV/AIDS REPORTS (2020)

Add to Collection

Article Immunology

Lack of HIV-1 integrase inhibitor resistance among 392 antiretroviral-naive individuals in a tertiary care hospital in Beijing, China

Lifeng Liu et al.

AIDS (2019)

Add to Collection

Article Virology

Antiviral activity of HIV-1 integrase strand-transfer inhibitors against mutants with integrase resistance-associated mutations and their frequency in treatment-naive individuals

Nicolas A. Margot et al.

JOURNAL OF MEDICAL VIROLOGY (2019)

Add to Collection

Article Immunology

Global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2017, and forecasts to 2030, for 195 countries and territories: a systematic analysis for the Global Burden of Diseases, Injuries, and Risk Factors Study 2017

Tahvi D. Frank et al.

LANCET HIV (2019)

Add to Collection

Article Infectious Diseases

Phenotypic analysis of HIV-1 E157Q integrase polymorphism and impact on virological outcome in patients initiating an integrase inhibitor-based regimen

Charlotte Charpentier et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)

Add to Collection

Article Immunology

Accumulation of Multiple Mutations In Vivo Confers Cross-Resistance to New and Existing Integrase Inhibitors

Wendy W. Zhang et al.

JOURNAL OF INFECTIOUS DISEASES (2018)

Add to Collection

Review Virology

HIV drug resistance against strand transfer integrase inhibitors

Kaitlin Anstett et al.

RETROVIROLOGY (2017)

Add to Collection

Article Immunology

Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies

Adam Trickey et al.

LANCET HIV (2017)

Add to Collection

Article Medicine, General & Internal

Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy

Alison J. Rodger et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)

Add to Collection

Article Medicine, General & Internal

Antiretroviral Therapy for the Prevention of HIV-1 Transmission

M. S. Cohen et al.

NEW ENGLAND JOURNAL OF MEDICINE (2016)

Add to Collection

Article Microbiology

Multiple Genetic Pathways Involving Amino Acid Position 143 of HIV-1 Integrase Are Preferentially Associated with Specific Secondary Amino Acid Substitutions and Confer Resistance to Raltegravir and Cross-Resistance to Elvitegravir

Wei Huang et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)

Add to Collection

Review Cell Biology

Current progress of China's free ART program

FJ Zhang et al.

CELL RESEARCH (2005)

Add to Collection

© Peeref 2019-2024. All rights reserved.